CHIODERA, Paolo
 Distribuzione geografica
Continente #
NA - Nord America 12.898
AS - Asia 9.733
EU - Europa 6.202
SA - Sud America 1.140
AF - Africa 458
Continente sconosciuto - Info sul continente non disponibili 48
OC - Oceania 13
AN - Antartide 1
Totale 30.493
Nazione #
US - Stati Uniti d'America 12.470
SG - Singapore 3.720
CN - Cina 2.740
VN - Vietnam 1.363
FI - Finlandia 1.240
IE - Irlanda 1.126
SE - Svezia 924
DE - Germania 881
BR - Brasile 862
HK - Hong Kong 673
UA - Ucraina 576
TR - Turchia 479
ZA - Sudafrica 361
IT - Italia 360
FR - Francia 297
NL - Olanda 292
CA - Canada 283
GB - Regno Unito 154
IN - India 140
BD - Bangladesh 112
AR - Argentina 90
RU - Federazione Russa 85
IQ - Iraq 63
MX - Messico 56
BE - Belgio 50
EC - Ecuador 48
PH - Filippine 47
PL - Polonia 45
ID - Indonesia 43
ES - Italia 39
PK - Pakistan 39
CO - Colombia 38
JP - Giappone 37
VE - Venezuela 36
SA - Arabia Saudita 34
TH - Thailandia 29
KR - Corea 27
UZ - Uzbekistan 25
AT - Austria 23
CI - Costa d'Avorio 22
IR - Iran 22
LT - Lituania 20
CL - Cile 19
EU - Europa 18
PE - Perù 18
KE - Kenya 17
AZ - Azerbaigian 16
JM - Giamaica 15
MA - Marocco 15
PY - Paraguay 15
EG - Egitto 14
MY - Malesia 13
AL - Albania 11
CR - Costa Rica 11
HN - Honduras 11
IL - Israele 11
TW - Taiwan 11
NP - Nepal 10
AU - Australia 9
CZ - Repubblica Ceca 9
JO - Giordania 9
NO - Norvegia 9
HU - Ungheria 8
KZ - Kazakistan 8
NI - Nicaragua 8
TT - Trinidad e Tobago 8
UY - Uruguay 8
KG - Kirghizistan 7
LU - Lussemburgo 7
OM - Oman 7
PA - Panama 7
PT - Portogallo 7
AE - Emirati Arabi Uniti 6
BG - Bulgaria 6
DO - Repubblica Dominicana 6
DZ - Algeria 6
RO - Romania 6
SV - El Salvador 6
AM - Armenia 5
BH - Bahrain 5
BO - Bolivia 5
LB - Libano 5
PS - Palestinian Territory 5
TN - Tunisia 5
ET - Etiopia 4
GT - Guatemala 4
LK - Sri Lanka 4
NZ - Nuova Zelanda 4
SK - Slovacchia (Repubblica Slovacca) 4
SY - Repubblica araba siriana 4
AO - Angola 3
BB - Barbados 3
CH - Svizzera 3
DK - Danimarca 3
MN - Mongolia 3
PR - Porto Rico 3
QA - Qatar 3
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
BZ - Belize 2
Totale 30.424
Città #
Singapore 1.953
Ashburn 1.734
Chandler 1.284
Jacksonville 1.161
Dublin 1.122
San Jose 944
Santa Clara 937
Beijing 730
Hong Kong 646
Dallas 643
Dearborn 440
Izmir 439
Ho Chi Minh City 431
Council Bluffs 349
Johannesburg 345
Nanjing 338
Hanoi 320
Boardman 264
San Mateo 254
Princeton 234
Los Angeles 217
Lauterbourg 207
Toronto 185
Shanghai 170
Munich 140
Ann Arbor 138
Des Moines 132
Nanchang 127
New York 121
Shenyang 119
Düsseldorf 116
Wilmington 110
Helsinki 108
Kunming 103
Buffalo 76
Woodbridge 76
Columbus 75
Hebei 69
São Paulo 68
Jinan 66
Haiphong 65
Hefei 58
Moscow 56
Tianjin 56
Brussels 50
Atlanta 48
Leawood 48
Grafing 47
Guangzhou 47
Da Nang 46
Turku 44
Seattle 40
London 38
Parma 38
Changsha 37
Jiaxing 37
Rome 36
Brooklyn 33
Warsaw 33
Tokyo 32
Orem 30
Phoenix 30
Redondo Beach 30
Chicago 29
Denver 29
Chennai 28
Hangzhou 26
Campinas 24
Falkenstein 24
Hải Dương 24
Pune 24
San Francisco 24
Milan 23
Rio de Janeiro 23
Zhengzhou 23
Abidjan 22
Baghdad 22
Augusta 21
Biên Hòa 21
Monmouth Junction 21
Montreal 21
Tashkent 21
Amsterdam 20
Stockholm 19
Dhaka 18
Houston 18
Ottawa 18
Bremen 17
Belo Horizonte 16
Charlotte 16
Fremont 16
Fuzhou 16
Mumbai 16
Nuremberg 16
Poplar 16
Ardabil 15
Can Tho 15
Frankfurt am Main 15
Manchester 15
Ninh Bình 15
Totale 18.717
Nome #
Different effects of aging on the opioid mechanisms controlling gonadotropin and cortisol secretion in man. 386
ADRENOCORTICOTROPIC HORMONE/CORTISOL RESPONSE TO PHYSICAL EXERCISE IN ABSTINENT ALCOHOLIC PATIENTS 283
Increased Arginine-Vasopressin Response to Hypertonic Stimulation and Upright Posture in Idiopathic Hyperprolactinemia 214
Livelli di prolattina, deidroepiandrosterone solfato, cortisolo, testosterone e 17-beta-estradiolo nell'alcolismo cronico. 205
Different effects of baclofen on LH and cortisol responses to naloxone in normal men. 193
5-HT3 serotonergic receptor mediation of hypoglycemia-induced arginine-vasopressin but not oxytocin secretion in normal men. 187
Studio parallelo di gonadotropine e prolattina in pazienti amenorroiche. 181
Gonadotropine, prolattina e tireotropina nella S. di Klinefelter. 179
Inhibition by somatostatin of LH-RH-induced LH release in normal menstruating women. 179
Alpha2-adrenergic and histamine H1 and H2-receptors do not mediate arginine-vasopressin release in response to insulin induced hypoglycemia in man. 178
Abnormal arginine vasopressin response to cigarette smoking and metoclopramide, but not insulin induced hypoglycemia in elderly subjects. 178
Protein Kinase Cε Regulates Proliferation and Cell Sensitivity to TGF-1β of CD4+ T Lymphocytes: Implications for Hashimoto Thyroiditis 177
5HT1-, but not 5HT2- serotonergic or M1-, M2-muscarinic cholinergic or dopaminergic receptors mediate the ACTH/cortisol response to metoclopramide. 175
Abnormal arginine vasopressin responses to metoclopramide and insulin induced hypoglycemia in type I diabetes mellitus. 174
Oxytocin administration does not alter growth hormone response to insulin induced hypoglycemia in normal men. 174
Inhibitory effect of somatostatin on the NPY response to insulin-induced hypoglycemia and the role of endogenous opioids 172
Different effect of metoclopramide and domperidone on GH release in type 1 male diabetics. 172
The infusion of somatostatin reduces the arginine vasopressin response to insulin induced hypoglycemia in man. 172
Abnormal growth hormone and cortisol but not thyroid stimulating hormone response to an intravenous glucose tolerance test in normal weight bulimic women. 172
Cholinergic- muscarinic-receptors participate in growth hormone secretion induced by lysine-8-vasopressin in man. 171
: Beta-endorphin, ACTH and cortisol secretion rhythms in abstinent alcoholics. 170
Effect of serotonergic system on AVP secretion induced by physical exercise 169
Abnormal plasma oxytocin and b-endorphin levels in alcoholics after short and long-term abstinence. 168
Effect of muscarinic and nicotinic-cholinergic blockade on the glucagon response to insulin-induced hypoglycemia in normal men. 168
Naloxone decreases the inhibitory effect of alprazolam on the release of adrenocorticotropin/cortisol induced by physical exercice in man 167
Naloxone decreases the inhibitory effect of somatostatin on GH release induced by cigarette smoking in man 167
Gonadotropins, prolactin and thyrotropin (basal value and pituitary responses) in infertile male patients. 166
ACTH and Beta-Endorphin responses to physical exercise in adolescent women tested for anxiety and frustration 166
Oxytocin reduces angiotensin II-induced ACTH release in men. 165
Arginine vasopressin secretion in non obese women with polycystic ovary syndrome. 165
Glucagon response to insulin-induced hypoglycemia in obese men. 165
Alterazione del controllo oppioide delle gonadotropine, ma non del cortisolo nell'uomo anziano. 165
Dopaminergic, but not cholinergic involvement in regulation of hypoglycemia-induced oxytocin release in man. 164
Sugli effetti di un trattamento policorticoide su gonadotropine, PRL e TSH (valori basali e risposta ipofisaria). 163
The growth hormone response to thyrotropin-releasing hormone in insulin-dependent diabetics involves a cholinergic mechanism. 161
Comportamento del settore gonadotropinico nella patologia espansiva diencefalo-ipofisaria prima e dopo trattamento neurochirurgico. 160
Age-related decreased in the opioid control of LH secretion during reproductive years in normal men. 160
Age-related changed in growth hormone (GH) secretion in normally cycling women. 159
Lysine-vasopressin inhibits the effect of oxytocin on the insulin response to glucose in normal man. 159
Age-dependent decrease in the growth hormone (GH) response to GH releasing hormone in normally cicling women. 158
GLUCORECEPTORS LOCATED IN THE BRAIN MEDIATE NPY RELEASE INDUCED BY HYPOGLICEMIA IN NORMAL MEN 157
Considerazioni sul comportamento della prolattina nelle displasie prostatiche. 157
Gn-RH test for hypogonadic men. 156
Alterata risposta secretiva del GH allo stimolo GABAergico nel morbo di Parkinson. 155
LH, FSH, TSH and PRL (basal values and pituitary responses) in oligo- and azospermic patients. 154
Abnormal effect of cigarette smoking on pituitary hormone secretions in insulin-dependent diabetes mellitus. 154
Effect of potentiation of cholinergic tone by pyridostigmine on the growth hormone (GH) response to GH-releasing hormone in elderly men. 152
Iperresponsività nell'anziano dell'arginin-vasopressina a stimolazione con fumo di sigaretta o con metoclopramide, ma non con ipoglicemia insulinica. 151
Effect of oxytocin on growth hormone (GH) secretion in response to arginin-vasopressin. 150
Histaminergic H1 and H2 receptors do not mediate cortisol release in response to naloxone in normal men. 150
Effect of lysine vasopressin on basal and TRH stimulated TSH and PRL release in normal men. 150
Failure of metergoline to antagonize naloxone induced cortisol rise in man. 149
La somministrazione endovenosa di ossitocina non determina variazioni nelle concentrazioni di prolattina, TSH e GH in un gruppo di soggetti di sesso maschile. 148
Stimulatory effect of naloxone on plasma cortical in humans: possible direct stimulatory action at the adrenal cortex. 148
Effect of metoclopramide on serum GH levels in normal women. 148
Effect of Naloxone on the LH response to intravenously-infused substance P in normal men 147
Patologia espansiva ipotalamo-ipofisaria: studio parallelo di TSH e PRL. 147
Free fatty acids inhibit adrenocorticotropin and cortisol secretion stimulated by physical exercise in normal men. 146
Cholinergic mediation of growth hormone secretion induced by thyrotropin-releasing hormone in cirrhotic patients. 146
Influenza dell'età sulla responsività ipofisaria GH- e ACTH-secernente alla lisin vasopressina. 146
Lysine-vasopressin does not affect basal and LH-RH stimulated LH and FSH release during the menstrual cycle of normal women. 146
Arginine-vasopressin (AVP) responses to osmotic, pressure-volumetric and hypoglycemic stimuli in women with polycistic ovaries (PCO) 146
Effect of naloxone on the inhibitory effect of melatonin on the release of arginine-vasopressin induced by physical exercise in man 145
Iperresponsività nell'anziano dell'arginin-vasopressina a stimolazione con fumo di sigaretta o con metoclopramide, ma non con ipoglicemia insulinica. 145
Effect of pharmacological doses of oxytocin on insulin response to glucose in man. 145
Hypoglycemia induced arginine vasopressin and oxytocin release is mediated by glucoreceptors located inside the blood brain barrier 145
TSH and PRL responses to domperidone and TRH in men with insulin-dependent diabetes mellitus of different duration. 144
Oxytocin does not modify glucagon- or calcitonin induced ACTH/Cortisol rise in humans. 144
Arginine Vasopressin and Oxytocin responses to angiotensin II are mediated by AT1 receptor subtype in normal men 144
Effect of nitric oxide on basal and TRH- or metoclopramide-stimulated prolactin release in normal men 144
Endogenous opioid mediation of the inhibitory effect of ethanol on the prolactin response to breast stimulation in normal women. 143
Risposta di TSH e PRL al TRH nella patologia nodulare tiroidea 143
Influence of residual C-peptide secretion on the arginine-vasopressin response to hypoglycemia and metergoline in insulin-dependent diabetes. 143
Growth hormone responses to GHRH, clonidine and insulin-induced hypoglycemia in normal weight bulimic women. 143
Intravenously infused Substance P is unable to change basal and TRH-stimulated PRL secretion in normal men. 142
Circadian vairiations in plasma ACTH, cortisol and beta-endorphin levels in normal weight bulimic women. 142
Effect of histaminergic H1- and H2-receptor antagonist on neurophysin release in response to nicotine from cigarette smoking in normal men. 142
Effect of systemic oxytocin administration on dexamethasone-induced leptin secretion in normal and obese men. 142
Nicotinic-cholinergic involvement in arginine-vasopressin response to insulin-induced hypoglycemia in normal men. 140
Profili ormonali della sindrome premestruale 140
Alteration in dopaminergic function in abstinent alcoholics. 140
Effect of naloxone on oxytocin-induced cortisol decrease in normal men. 140
Effect of cimetidine on PRL secretion in elderly subjects. 139
Inhibition by oxytocin of Endothelin-1-induced ACTH secretion in normal men. 138
The gabaergic control of prolactin release is not affected by insulin-dependent diabetes mellitus: evidence from studies with sodium valproate. 138
Dopaminergic and opioid receptor antagonist do not modify the secretory response of growth hormone to lysine-vasopressin in normal subjects. 138
Livelli di deidroepiandrosterone urinario in un gruppo di pazienti di sesso maschile portatori di iperprolattinemia di tipo funzionale. 137
Gabaergic mediation of the inhibitory effect of endogenous opioids on the arginine vasopressin and oxytocin responses to nicotine from cigarette smoking 137
Reduction of lysine vasopressin induced GH, but not ACTH release in elderly men. 137
Effect of domperidone on cortisol secretion in normal men. 136
Effect of residual endogenous insulin secretion on the abnormal oxytocin response to hypoglycemia in insulin-dependent diabetics. 136
Antiserotonergic and antihistaminergic agents do not antagonize naloxone-induced cortisol secretion in normal men. 136
Effect of naloxone on neurophysin secretion in normal women. 135
TSH and PRL responses to domperidone in men with insulin-dependent diabetes mellitus (IDDM) 135
Somatostatin reduces Neuropeptide Y rise induced by physical exercise. 134
Stimulatory effect of naloxone on plasma cortisol in human: possible direct stilulatory action at the adrenal cortex 134
Effect of naloxone on neurophysin secretion induced by nicotine in man. 134
Naloxone decreases the inhibiting effect of ethanol on the release of arginine-vasopressin induced by cigarette smoking in man. 133
Livelli ematici di testosterone in corso di iperprolattinemia funzionale ed organica. 133
Effetto della somministrazione di ossitocina sulla secrezione di prolattina nella donna normale. 133
Totale 15.809
Categoria #
all - tutte 105.057
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 105.057


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.088 0 0 0 19 23 56 168 208 53 81 63 417
2022/20234.136 460 403 299 318 310 502 19 285 1.408 17 91 24
2023/20241.405 88 170 23 42 106 234 43 365 33 40 119 142
2024/20254.643 86 272 367 230 480 695 30 206 474 427 407 969
2025/202610.323 1.131 828 1.320 896 1.696 727 1.210 369 1.191 669 170 116
2026/20271.839 243 609 566 421 0 0 0 0 0 0 0 0
Totale 30.493